Cargando…

WHODAS Assessment Feasibility and Mental Health Impact on Functional Disability in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE), besides rheumatological dysfunction, manifests in neuropsychiatric disorders like depression and anxiety. Mental health illnesses in SLE patients have a high prevalence and a profound impact on quality of life, generating an increased disability and premature mort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duca, Liliana, Roman, Nadinne Alexandra, Miron, Aliana, Teodorescu, Andreea, Dima, Lorena, Ifteni, Petru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222861/ https://www.ncbi.nlm.nih.gov/pubmed/35742104 http://dx.doi.org/10.3390/healthcare10061053

Ejemplares similares

Association between Inflammation and Thrombotic Pathway Link with Pathogenesis of Depression and Anxiety in SLE Patients
por: Duca, Liliana, et al.
Publicado: (2023)

Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis
por: Teodorescu, Andreea, et al.
Publicado: (2021)

Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study
por: Miron, Ana-Aliana, et al.
Publicado: (2022)

Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
por: Ifteni, Petru, et al.
Publicado: (2020)

Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection
por: Moga, Silvia, et al.
Publicado: (2022)

Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study
por: Miron, Ana Aliana, et al.
Publicado: (2023)

Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania
por: Miron, Ana A., et al.
Publicado: (2022)

Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)
por: Ifteni, Petru, et al.
Publicado: (2021)

Measuring disability in multiple sclerosis: the WHODAS 2.0
por: Young, Carolyn A., et al.
Publicado: (2023)

Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature
por: Teodorescu, Andreea, et al.
Publicado: (2017)

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment
por: Moga, Silvia, et al.
Publicado: (2021)

WHODAS 2.0-BO: normative data for the assessment of disability in older adults
por: Ferrer, Michele Lacerda Pereira, et al.
Publicado: (2019)

COT-03 EVALUATING FUNCTIONING AND DISABILITY OF A PATIENT WITH BRAIN TUMOR BY WHODAS
por: Ishita, Kohei, et al.
Publicado: (2019)

Effects of Hearing Disability on the Employment Status Using WHODAS 2.0 in Taiwan
por: Chao, Pin-Zhir, et al.
Publicado: (2020)

Delayed identification and diagnosis of Huntington’s disease due to psychiatric symptoms
por: Pascu, Alina Mihaela, et al.
Publicado: (2015)

Validation of the “World Health Organization Disability Assessment Schedule for Children, WHODAS-Child” in Rwanda
por: Scorza, Pamela, et al.
Publicado: (2013)

Psychometric evaluation of the WHODAS 2.0 and prevalence of disability in a Swedish general population
por: Norén, Paulina, et al.
Publicado: (2023)

Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
por: Ifteni, Petru, et al.
Publicado: (2017)

WHODAS measurement properties for women with dysmenorrhea
por: de Arruda, Guilherme Tavares, et al.
Publicado: (2023)

Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases
por: Garin, Olatz, et al.
Publicado: (2010)

Comparison of disability level between Early and Late Onset Parkinson’s Disease using WHODAS 2
por: Nascimento, Isaíra Almeida Pereira da Silva, et al.
Publicado: (2023)

Measurement of patient reported disability using WHODAS 2.0 before and after surgical intervention in Madagascar
por: White, Michelle C., et al.
Publicado: (2018)

Schizophrenia with and without obsessive-compulsive symptoms: a comparative analysis of performance on trail making test and disability on WHODAS
por: Singh, Apala, et al.
Publicado: (2020)

Is WHODAS 2.0 Useful for Colorectal Cancer Survivors?
por: Lee, Hyun Haeng, et al.
Publicado: (2017)

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
por: Richter, Patricia, et al.
Publicado: (2023)

An item analysis according to the Rasch model of the German 12-item WHO Disability Assessment Schedule (WHODAS 2.0)
por: Vaganian, Lusine, et al.
Publicado: (2021)

The psychometric properties and minimal clinically important difference for disability assessment using WHODAS 2.0 in critically ill patients
por: Higgins, Alisa M., et al.
Publicado: (2023)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Validation of the 36-item version of the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) for assessing women's disability and functioning associated with maternal morbidity
por: Silveira, Carla, et al.
Publicado: (2017)

Neuropsychiatric Systemic Lupus Erythematosus
por: Popescu, Alexandra, et al.
Publicado: (2011)

Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023)

Using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for Predicting Institutionalization of Patients With Dementia in Taiwan
por: Huang, Shih-Wei, et al.
Publicado: (2015)

Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease
por: Kim, Ji-In, et al.
Publicado: (2015)

Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil
por: Tavares, Patrícia Aparecida, et al.
Publicado: (2023)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
por: Richter, Patricia, et al.
Publicado: (2022)

Ethical considerations about informed consent in physiotherapy in Romania
por: Roman, Nadinne, et al.
Publicado: (2019)

The 12 items Amharic version WHODAS-2 showed cultural adaptation and used to measure disability among road traffic trauma victims in Ethiopia
por: Denu, Zewditu Abdissa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_25ugv2ilf82sahqbkmca54iopp